FDA Approved: SKYLA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for SKYLA (levonorgestrel), Bayer's intrauterine contraceptive device, resulting in labeling updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• SKYLA (LEVONORGESTREL)

Snippet

SUPPL AP for SKYLA (LEVONORGESTREL)